Search

1 article for “MAO-B inhibitors”

• Published Subscription Review Article 31 Dec 2024

  Comparative Efficacy and Safety of Safinamide and Rasagiline in the Treatment of Parkinson’s Disease: A Meta-Analysis and Systematic Review

  By Joy Das, Utpal Bhui, Soumyadip Nayak, Rahul Bishayee, Udita Dutta, Poulomi Mishra, Radheshyam Pal, Pratibha Bhowmick, Mithun Bhowmick

  Abstract: Background: Recent studies have suggested Rasagiline and Safinamide monotherapy as potential management options for Parkinson’s disease. Parkinson’s disease, a neurological disorder characterized by tremors and movement difficulties, necessitates treatments aimed at managing clinical symptoms. Levodopa remains the primary effective treatment for Parkinson’s disease symptoms; however, its long-term use often leads to motor complications in many patients. Additional therapeutic drugs, such as dopamine agonists and monoamine oxidase B inhibitors, including Safinamide …

  Published in Research and Reviews: A Journal of Pharmacology · Vol. 14, Issue 3, 2024 · pp. 74–91 Read article →